Labcorp is now offering Roche Diagnostics' recently FDA-cleared Alzheimer’s disease blood test to help primary care doctors ...
The company struck three deals in New York last year as part of its push to acquire hospital and regional testing labs.
FDA clears 1st blood test for Alzheimer’s to help primary care clinicians assess cognitive decline without brain scans or lumbar punctures.
While the method shows promise, some experts say that other self-collection devices are more readily available ...
The company plans to begin using the instrument in its Burlington, North Carolina, lab in the first quarter of the year and then move the technology into other facilities.
Under the agreement, Labcorp will become the clinically integrated laboratory provider of choice for all SOMOS providers, care teams, and patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results